Cargando…
Cytomegalovirus infection in brain tumors: A potential new target for therapy?
Emerging evidence demonstrate a high prevalence of cytomegalovirus (CMV) proteins and nucleic acids in different tumors. CMV is confined to tumor cells and non-cancer cells in close proximity to tumors are consistently virus negative. CMV confers both oncogenic and oncomodulatory mechanisms, and may...
Autores principales: | Söderberg-Nauclér, Cecilia, Johnsen, John Inge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429578/ https://www.ncbi.nlm.nih.gov/pubmed/22934266 http://dx.doi.org/10.4161/onci.19441 |
Ejemplares similares
-
Is human cytomegalovirus a target in cancer therapy?
por: Johnsen, John Inge, et al.
Publicado: (2011) -
Immunological targeting of cytomegalovirus for glioblastoma therapy
por: Nair, Smita K, et al.
Publicado: (2014) -
Targeting the tumor mutanome for personalized vaccination therapy
por: Kreiter, Sebastian, et al.
Publicado: (2012) -
New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
por: Söderberg-Nauclér, Cecilia
Publicado: (2022) -
The relationship between malignant and tumor-associated cells provides a new strategy for targeted diagnosis and therapy
por: Lu, Xiaoling, et al.
Publicado: (2013)